PEG10
Basic information
Region (hg38): 7:94656325-94669695
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn genetic diseases (10 variants)
- not provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PEG10 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 10 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 8 | 3 | 0 |
Variants in PEG10
This is a list of pathogenic ClinVar variants found in the PEG10 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-94656435-G-A | Likely benign (Mar 09, 2019) | |||
7-94663366-G-A | not specified | Likely benign (Dec 21, 2022) | ||
7-94663367-G-C | not specified | Uncertain significance (Dec 14, 2023) | ||
7-94663401-C-A | not specified | Uncertain significance (Nov 10, 2022) | ||
7-94663428-A-G | not specified | Uncertain significance (Sep 03, 2024) | ||
7-94663446-A-G | not specified | Uncertain significance (Jun 29, 2023) | ||
7-94663458-G-C | not specified | Uncertain significance (Jan 08, 2024) | ||
7-94663543-C-T | not specified | Uncertain significance (Oct 06, 2024) | ||
7-94663632-G-A | not specified | Uncertain significance (Dec 30, 2023) | ||
7-94663662-A-C | not specified | Uncertain significance (Sep 27, 2024) | ||
7-94663718-T-A | not specified | Likely benign (Dec 14, 2023) | ||
7-94663740-C-T | not specified | Likely benign (Jun 05, 2023) | ||
7-94663767-C-T | not specified | Uncertain significance (Jun 21, 2022) | ||
7-94663770-C-G | not specified | Uncertain significance (Feb 03, 2022) | ||
7-94663789-G-A | not specified | Uncertain significance (Mar 11, 2024) | ||
7-94663849-C-T | not specified | Uncertain significance (Apr 13, 2022) | ||
7-94663868-G-C | not specified | Uncertain significance (Aug 10, 2024) | ||
7-94663959-G-A | not specified | Uncertain significance (Dec 09, 2024) | ||
7-94664034-G-A | not specified | Uncertain significance (Apr 20, 2024) | ||
7-94664298-C-G | not specified | Uncertain significance (Sep 09, 2024) | ||
7-94664298-C-T | not specified | Uncertain significance (Jul 09, 2021) | ||
7-94664319-C-T | not specified | Uncertain significance (Dec 12, 2023) | ||
7-94664395-G-A | not specified | Uncertain significance (Apr 18, 2023) | ||
7-94664421-C-T | not specified | Uncertain significance (Jan 22, 2024) | ||
7-94664503-C-T | not specified | Uncertain significance (Feb 28, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PEG10 | protein_coding | protein_coding | ENST00000482108 | 1 | 13371 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.873 | 0.127 | 124613 | 0 | 3 | 124616 | 0.0000120 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.08 | 123 | 208 | 0.593 | 0.0000134 | 2130 |
Missense in Polyphen | 42 | 68.973 | 0.60894 | 731 | ||
Synonymous | 1.34 | 69 | 84.7 | 0.814 | 0.00000589 | 646 |
Loss of Function | 2.81 | 1 | 11.1 | 0.0900 | 7.27e-7 | 108 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000187 | 0.0000177 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Prevents apoptosis in hepatocellular carcinoma (HCC) cells through interaction with SIAH1, a mediator of apoptosis. May also have a role in cell growth promotion and hepatoma formation. Inhibits the TGF-beta signaling by interacting with the TGF-beta receptor ALK1. When overexpressed, induces the formation of cellular extension, such as filipodia in association with ALK1. Involved at the immediate early stage of adipocyte differentiation (By similarity). May bind to the 5'-GCCTGTCTTT-3' DNA sequence of the MB1 domain in the myelin basic protein (MBP) promoter (By similarity). {ECO:0000250, ECO:0000269|PubMed:12810624, ECO:0000269|PubMed:15611116, ECO:0000269|PubMed:16423995, ECO:0000269|PubMed:17369855}.;
- Pathway
- Validated targets of C-MYC transcriptional activation
(Consensus)
Recessive Scores
- pRec
- 0.110
Intolerance Scores
- loftool
- rvis_EVS
- -0.27
- rvis_percentile_EVS
- 33.97
Haploinsufficiency Scores
- pHI
- 0.707
- hipred
- Y
- hipred_score
- 0.507
- ghis
- 0.673
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.539
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Peg10
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; growth/size/body region phenotype; cellular phenotype;
Gene ontology
- Biological process
- apoptotic process;cell differentiation;negative regulation of transforming growth factor beta receptor signaling pathway
- Cellular component
- nucleus;cytoplasm;cytosol
- Molecular function
- DNA binding;RNA binding;protein binding;zinc ion binding